Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Impact of pediatric exclusivity on drug labeling and demonstrations of efficacy.

Wharton GT, Murphy MD, Avant D, Goldsmith JV, Chai G, Rodriguez WJ, Eisenstein EL.

Pediatrics. 2014 Aug;134(2):e512-8. doi: 10.1542/peds.2013-2987. Epub 2014 Jul 14.

PMID:
25022732
2.

Alternate endpoints and clinical outcome assessments in pediatric ulcerative colitis registration trials.

Sun H, Lee JJ, Papadopoulos EJ, Lee CS, Nelson RM, Sachs HC, Rodriguez WJ, Mulberg AE.

J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):12-7. doi: 10.1097/MPG.0000000000000186.

PMID:
24121142
3.

Vitamin d status and spine surgery outcomes.

Rodriguez WJ, Gromelski J.

ISRN Orthop. 2013 Apr 11;2013:471695. doi: 10.1155/2013/471695. eCollection 2013. Review.

4.

The globalization of pediatric clinical trials.

Dunne J, Murphy MD, Rodriguez WJ.

Pediatrics. 2012 Dec;130(6):e1583-91. doi: 10.1542/peds.2011-3687. Epub 2012 Nov 5.

PMID:
23129087
5.

Extrapolation of adult data and other data in pediatric drug-development programs.

Dunne J, Rodriguez WJ, Murphy MD, Beasley BN, Burckart GJ, Filie JD, Lewis LL, Sachs HC, Sheridan PH, Starke P, Yao LP.

Pediatrics. 2011 Nov;128(5):e1242-9. doi: 10.1542/peds.2010-3487. Epub 2011 Oct 24.

PMID:
22025597
6.

Amoxicillin for postexposure inhalational anthrax in pediatrics: rationale for dosing recommendations.

Alexander JJ, Colangelo PM, Cooper CK, Roberts R, Rodriguez WJ, Murphy MD.

Pediatr Infect Dis J. 2008 Nov;27(11):955-7. doi: 10.1097/INF.0b013e31817bf9a9.

PMID:
18833025
7.

Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.

DeVincenzo JP, Hall CB, Kimberlin DW, Sánchez PJ, Rodriguez WJ, Jantausch BA, Corey L, Kahn JS, Englund JA, Suzich JA, Palmer-Hill FJ, Branco L, Johnson S, Patel NK, Piazza FM.

J Infect Dis. 2004 Sep 1;190(5):975-8. Epub 2004 Jul 27.

PMID:
15295704
8.

What outcome measures are needed to assess gastroesophageal reflux disease in children? what study design is appropriate? what new knowledge is needed?

Gold BD, Co J, Colletti RB, Euler AR, Ferris TG, Fitzgerald JF, Flores AF, Gallo-Torres H, Orenstein SR, Rodriguez WJ, Willging P.

J Pediatr Gastroenterol Nutr. 2003 Nov-Dec;37 Suppl 1:S72-5. Review. No abstract available.

PMID:
14685083
9.

Current regulatory policies regarding pediatric indications and exclusivity.

Rodriguez WJ, Roberts R, Murphy D.

J Pediatr Gastroenterol Nutr. 2003 Nov-Dec;37 Suppl 1:S40-5.

PMID:
14685077
10.

Evaluation of diagnostic tests for influenza in a pediatric practice.

Rodriguez WJ, Schwartz RH, Thorne MM.

Pediatr Infect Dis J. 2002 Mar;21(3):193-6.

PMID:
12005080
11.

Optochin resistance in Streptococcus pneumoniae: mechanism, significance, and clinical implications.

Pikis A, Campos JM, Rodriguez WJ, Keith JM.

J Infect Dis. 2001 Sep 1;184(5):582-90. Epub 2001 Jul 26.

PMID:
11474432
12.

Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl.

Porcalla AR, Rodriguez WJ.

South Med J. 2001 Apr;94(4):435-7.

PMID:
11332914
13.

The pediatric forum. Physician use of a telephone access line for infectious disease consultation.

Jantausch BA, O'Donnell R, Rodriguez WJ.

Arch Pediatr Adolesc Med. 2000 Nov;154(11):1170-1. No abstract available.

PMID:
11074864
14.
15.

Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.

Odio CM, Puig JR, Feris JM, Khan WN, Rodriguez WJ, McCracken GH Jr, Bradley JS.

Pediatr Infect Dis J. 1999 Jul;18(7):581-90.

PMID:
10440432
16.

Management strategies for respiratory syncytial virus infections in infants.

Rodriguez WJ.

J Pediatr. 1999 Aug;135(2 Pt 2):45-50. Review.

PMID:
10431139
17.
18.

Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.

Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA.

Antimicrob Agents Chemother. 1999 May;43(5):1183-8.

19.

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ.

Pediatr Infect Dis J. 1999 Mar;18(3):223-31. Review. No abstract available.

PMID:
10093942
20.
21.

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.

Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M, Kramer A, Hemming V.

Pediatrics. 1997 Dec;100(6):937-42.

PMID:
9374560
22.

Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.

Pikis A, Donkersloot JA, Akram S, Keith JM, Campos JM, Rodriguez WJ.

J Antimicrob Chemother. 1997 Jul;40(1):105-8. Erratum in: J Antimicrob Chemother 1997 Sep;40(3):462.

PMID:
9249211
23.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.

Pediatrics. 1997 Mar;99(3):454-61.

PMID:
9041304
24.

Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin.

Meissner HC, Welliver RC, Chartrand SA, Fulton DR, Rodriguez WJ, Groothuis JR.

Pediatr Infect Dis J. 1996 Dec;15(12):1059-68. Review. No abstract available.

PMID:
8970212
25.

Increasing incidence of penicillin- and ampicillin-resistant middle ear pathogens.

Rodriguez WJ, Schwartz RH, Thorne MM.

Pediatr Infect Dis J. 1995 Dec;14(12):1075-8.

PMID:
8745021
26.

Criteria for studies of antibiotic therapy for acute otitis media.

Schwartz RH, Rodriguez WJ.

J Pediatr. 1995 Apr;126(4):677-8. No abstract available.

PMID:
7699558
27.

Streptococcus pneumoniae resistant to penicillin: incidence and potential therapeutic options.

Rodriguez WJ, Schwartz RH, Akram S, Khan WN.

Laryngoscope. 1995 Mar;105(3 Pt 1):300-4.

PMID:
7877420
28.

Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR.

Antimicrob Agents Chemother. 1995 Mar;39(3):668-71.

29.

Maternal plasma transfusion in the treatment of disseminated neonatal echovirus 11 infection.

Jantausch BA, Luban NL, Duffy L, Rodriguez WJ.

Pediatr Infect Dis J. 1995 Feb;14(2):154-5. No abstract available.

PMID:
7746702
30.

Penicillin-resistant pneumococci from pediatric patients in the Washington, DC, area.

Pikis A, Akram S, Donkersloot JA, Campos JM, Rodriguez WJ.

Arch Pediatr Adolesc Med. 1995 Jan;149(1):30-5.

PMID:
7827656
31.

Pediatric Plasmodium falciparium malaria: a ten-year experience from Washington, DC.

McCaslin RI, Pikis A, Rodriguez WJ.

Pediatr Infect Dis J. 1994 Aug;13(8):709-15. Review.

PMID:
7970971
32.

Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial.

Rodriguez WJ, Hall CB, Welliver R, Simoes EA, Ryan ME, Stutman H, Johnson G, Van Dyke R, Groothuis JR, Arrobio J, et al.

J Pediatr. 1994 Jul;125(1):129-35.

PMID:
8021762
33.

The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.

Rodriguez WJ, Wiedermann BL.

Adv Pediatr Infect Dis. 1994;9:125-59. Review. No abstract available.

PMID:
8123221
34.

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.

Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al.

N Engl J Med. 1993 Nov 18;329(21):1524-30.

35.

Spectroscopic and lasing properties of Ho:Tm:LuAG.

Barnes NP, Filer ED, Naranjo FL, Rodriguez WJ, Kokta MR.

Opt Lett. 1993 May 1;18(9):708-10.

PMID:
19802247
36.

Cefixime vs. cefaclor in the treatment of acute otitis media in children: a randomized, comparative study.

Rodriguez WJ, Khan W, Sait T, Chhabra OP, Bell TA, Akram S, Kohlbrenner VM.

Pediatr Infect Dis J. 1993 Jan;12(1):70-4.

PMID:
8417429
37.

[Advances in antimicrobial therapy].

Rodríguez WJ.

An Esp Pediatr. 1992 Jun;36 Suppl 48:132-4. Spanish.

PMID:
1636949
38.

Escherichia coli virulence factors and 99mTc-dimercaptosuccinic acid renal scan in children with febrile urinary tract infection.

Jantausch BA, Wiedermann BL, Hull SI, Nowicki B, Getson PR, Rushton HG, Majd M, Luban NL, Rodriguez WJ.

Pediatr Infect Dis J. 1992 May;11(5):343-9.

PMID:
1352870
39.

Human herpesvirus 7: antigenic properties and prevalence in children and adults.

Wyatt LS, Rodriguez WJ, Balachandran N, Frenkel N.

J Virol. 1991 Nov;65(11):6260-5.

40.

Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N.

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5922-6.

41.

Prospects of a rotavirus vaccine.

Singh-Naz N, Rodriguez WJ, Pedreira F.

Pediatr Ann. 1990 Dec;19(12):727-31. No abstract available.

PMID:
2177875
42.

Treatment of Pseudomonas meningitis with ceftazidime with or without concurrent therapy.

Rodriguez WJ, Khan WN, Cocchetto DM, Feris J, Puig JR, Akram S.

Pediatr Infect Dis J. 1990 Feb;9(2):83-7.

PMID:
2179845
43.

Sultamicillin (sulbactam/ampicillin) versus amoxycillin in the treatment of acute otitis media in children.

Rodriguez WJ, Khan WH, Sait T, Chhabra OP, Guarinello A, Smith AW, Ahmad S.

J Int Med Res. 1990;18 Suppl 4:78D-84D.

PMID:
2282972
44.

Amoxicillin as the drug of choice for acute otitis media: isn't it time for its reassessment in some areas of the country?

Schwartz RH, Rodriguez WJ.

Pediatr Infect Dis J. 1989 Nov;8(11):806. No abstract available.

PMID:
2594460
45.

Patience helps deal with patients.

Rodriguez WJ.

Dent Off. 1989 Oct;1(6):1, 5, 16. No abstract available.

PMID:
2639696
46.

Management of diarrheal illness.

Feigin RD, Fitzgerald JF, Rodriguez WJ, McCracken GH Jr.

Pediatr Infect Dis J. 1989 Aug;8(8):579-82. No abstract available.

PMID:
2771542
47.

Viral enteritis in the 1980s: perspective, diagnosis and outlook for prevention.

Rodriguez WJ.

Pediatr Infect Dis J. 1989 Aug;8(8):570-8. Review. No abstract available.

PMID:
2549497
48.

Computer simulation of exciton trapping in Cu2+-doped crystals of (CH3)4NMnCl3 and (CH3)4NMnBr3 : Significance of trap efficiency in one-dimensional systems.

Rodriguez WJ, Herman MF, McPherson GL.

Phys Rev B Condens Matter. 1989 Jun 15;39(18):13187-13192. No abstract available.

PMID:
9948217
49.

Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.

Feris J, Moledina N, Rodriguez WJ, Khan WN, Puig J, Wiedermann BL, Ahmad S.

Chemotherapy. 1989;35 Suppl 1:31-8.

PMID:
2731448
50.

Progress in antibacterial therapy: cephalosporins and quinolones.

Rodriguez WJ, Wiedermann BL.

Adv Pediatr Infect Dis. 1989;4:183-210. Review. No abstract available.

PMID:
2645901

Supplemental Content

Loading ...
Support Center